Business
Sotera Health Delivers Strong First-Quarter 2026 Results and Reaffirms 2026 Outlook
Q1 2026 net revenues increased 10.0%, or 6.5% on a constant currency basis, compared to Q1 2025Q1 2026 net income of $27 million or $0.09 per diluted share, compared to a net loss of $13 million or $0.05 per diluted share in Q1 2025Q1 2026 Adjusted EBITDA(1) increased 10.5%, or 6.9% on a constant currency basisQ1 2026 Adjusted EPS(1) of $0.18, an increase of 29% per diluted shareCompany reaffirms full-year 2026 outlook of 5.0% - 6.5% net revenues growth and 5.5% - 7.0% Adjusted EBITDA growth, bo
About this update from Sotera Health Company
[{"type":"image","alt":"Sotera Health Services, LLC","displaySize":"","headline":null,"caption":"Sotera Health Services, LLC","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":98,"url":"https://media.zenfs.com/en/globenewswire.com/7c10264f0078cb41fba86b2e1457b8ce"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/L2pNd6TjlnQunk65axTwwA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTEzNw--/https://media.zenfs.com/en/globenewswire.com/7c10264f0078cb41fba86b2e1457b8ce","width":300,"height":98}},"lazy":false},{"type":"list","items":[{"val":[{"type":"text","content":"Q1 2026 net revenues increased 10.0%, or 6.5% on a constant currency basis, compared to Q1 2025","length":95,"tagName":"p"}]},{"val":[{"type":"text","content":"Q1 2026 net income of $27 million or $0.09 per diluted share, compared to a net loss of $13 million or $0.05 per diluted share in Q1 2025","length":137,"tagName":"p"}]},{"val":[{"type":"text","content":"Q1 2026 Adjusted EBITDA(1) increased 10.5%, or 6.9% on a constant currency basis","length":80,"tagName":"p"}]},{"val":[{"type":"text","content":"Q1 2026 Adjusted EPS(1) of $0.18, an increase of 29% per diluted share","length":70,"tagName":"p"}]},{"val":[{"type":"text","content":"Company reaffirms full-year 2026 outlook of 5.0% - 6.5% net revenues growth and 5.5% - 7.0% Adjusted EBITDA growth, both on a constant currency basis","length":149,"tagName":"p"}]},{"val":[{"type":"text","content":"Company announced planned CEO transition in a separate release today","length":68,"tagName":"p"}]}],"tagName":"ul","bulletedList":true,"length":599,"olType":false},{"type":"text","content":"CLEVELAND, May 05, 2026 (GLOBE NEWSWIRE) -- Sotera Health Company (“Sotera Health” or the “Company”) (Nasdaq: SHC), a leading global provider of mission-critical end-to-end sterilization solutions, lab testing and advisory services for the healthcare industry, today announced financial results for the three months ended March 31, 2026.","length":337,"tagName":"p"},{"type":"text","content":"“We delivered a strong start to the year, with solid revenue and Adjusted EBITDA growth while driving margin expansion,” said Chairman and Chief Executive Officer, Michael B. Petras, Jr. “Growth was driven by disciplined execution at Sterigenics and Nordion, and Nelson Labs came in as we outlined on our fourth-quarter 2025 earnings call. Based on our first-qu...